story of the week
Patient-Reported Outcomes of Trastuzumab Deruxtecan vs Treatment of Physician's Choice in HER2-Low MBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology